For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Avid Bioservices Inc (NASDAQ: CDMO) closed at $6.41 in the last session, up 0.31% from day before closing price of $6.39. In other words, the price has increased by $0.31 from its previous closing price. On the day, 0.51 million shares were traded. CDMO stock price reached its highest trading level at $6.66 during the session, while it also had its lowest trading level at $6.31.
Ratios:
We take a closer look at CDMO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.85 and its Current Ratio is at 1.35. In the meantime, Its Debt-to-Equity ratio is 1.07 whereas as Long-Term Debt/Eq ratio is at 1.06.
On March 14, 2023, KeyBanc Capital Markets Upgraded its rating to Overweight which previously was Sector Weight but kept the price unchanged to $20.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 12 ’24 when Kwietniak Matthew R. sold 274 shares for $6.77 per share. The transaction valued at 1,855 led to the insider holds 19,829 shares of the business.
Hart Daniel R sold 2,408 shares of CDMO for $14,857 on Jan 10 ’24. The Chief Financial Officer now owns 79,305 shares after completing the transaction at $6.17 per share. On Jan 10 ’24, another insider, Ziebell Mark R, who serves as the V. P., General Counsel of the company, sold 1,346 shares for $6.17 each. As a result, the insider received 8,305 and left with 63,269 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDMO now has a Market Capitalization of 405363264 and an Enterprise Value of 569370752. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.96 while its Price-to-Book (P/B) ratio in mrq is 2.21. Its current Enterprise Value per Revenue stands at 4.04 whereas that against EBITDA is -1136.469.
Stock Price History:
The Beta on a monthly basis for CDMO is 1.60, which has changed by -0.6707883 over the last 52 weeks, in comparison to a change of 0.2006725 over the same period for the S&P500. Over the past 52 weeks, CDMO has reached a high of $19.97, while it has fallen to a 52-week low of $4.07. The 50-Day Moving Average of the stock is -8.92%, while the 200-Day Moving Average is calculated to be -22.59%.
Shares Statistics:
According to the various share statistics, CDMO traded on average about 1.34M shares per day over the past 3-months and 868230 shares per day over the past 10 days. A total of 62.69M shares are outstanding, with a floating share count of 62.54M. Insiders hold about 1.11% of the company’s shares, while institutions hold 91.01% stake in the company. Shares short for CDMO as of 1711584000 were 10110394 with a Short Ratio of 7.57, compared to 1709164800 on 6593041. Therefore, it implies a Short% of Shares Outstanding of 10110394 and a Short% of Float of 19.09.
Earnings Estimates
The current rating of Avid Bioservices Inc (CDMO) is the result of assessments by Avid Bioservices, Inc. analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is $0.75, with high estimates of $11.60 and low estimates of $10.66.
